tradingkey.logo

Aveanna Healthcare Holdings Inc <AVAH.OQ> expected to post breakeven results a share - Earnings Preview

ReutersMar 11, 2025 12:38 PM
  • Aveanna Healthcare Holdings Inc AVAH.OQ AVAH.O is expected to show a rise in quarterly revenue when it reports results on March 13 for the period ending December 31 2024

  • The Atlanta Georgia-based company is expected to report a 4.3% increase in revenue to $499.61 million from $478.84 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Aveanna Healthcare Holdings Inc is for breakeven results per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 5 "hold" and 2 "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Aveanna Healthcare Holdings Inc is $5.25​, above​ its last closing price of $3.68. ​​​

The company's guidance on November 7 2024 for the period ended December 31 was for gross profit margin between 43% and 44%.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.01

-0.01

0.02

Beat

260

Jun. 30 2024

-0.01

-0.02

0.01

Beat

150

Mar. 31 2024

-0.05

-0.05

-0.03

Beat

36.8​

Dec. 31 2023

-0.02

-0.02

-0.02

Met

15.8

​​Sep. 30 2023

-0.03

-0.03

-0.03

Met

-12.5

Jun. 30 2023

-0.04

-0.04

-0.02

Beat

44.8​

Mar. 31 2023

-0.06

-0.06

-0.05

Beat

18.6

Dec. 31 2022

-0.01

-0.02

-0.03

Missed

-81

This summary was machine generated March 11 at 12:38 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI